Patterns of chemotherapy receipt among patients with hormone receptor-positive, HER2-negative breast cancer
ConclusionsWhile race was not strongly associated with chemotherapy receipt, younger age remains a strong predictor of chemotherapy receipt, even with adjustment for clinical factors and among women who receive genomic testing.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | HER2 | Hormones | Medicaid | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Rural Health | Study | Women